NHS contract income, VAT retail schemes, FP34 cash-flow planning, and the buying and selling moment. We work exclusively with pharmacy owners, buyers, sellers, and multi-store groups. Generalist firms handle your bookkeeping; we handle the parts of pharmacy finance that need specialist knowledge.
A community pharmacy is not a standard retail business. Income is reimbursement and remuneration under the NHS contract, not till takings. VAT applies differently to dispensing and OTC sales. The purchase price is dominated by goodwill attached to the NHS contract. None of this is exotic, but all of it is specific, and a generalist accountant who encounters it once a year handles it differently from one who works with it every week.
The questions facing a single-store owner running an NHS contract differ from those facing a first-time buyer, a seller planning an exit, a group operator managing associated-company rules, or a locum pharmacist sorting Self Assessment. Choose your situation for audience-specific guidance.
A community pharmacy is not a retail shop with a dispensary bolted on. Your income flows from the NHS under the Community Pharmacy Contractual Framework as reimbursement and remuneration, not till takings, and three things a generalist accountant routinely gets wrong (the FP34 cash lag, retrospective Category M margin adjustment, and your VAT-mixed status) compound into material errors month after month. We work exclusively with pharmacy owners because the contract literacy cannot be faked.
Buying a PharmacyWhen you buy a community pharmacy you are not buying a shop. You are buying an NHS contract, and market entry is regulated under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013. The broker finds the deal; we do the work the broker cannot: financial due diligence on the contract income, the share-versus-asset structuring decision, goodwill tax treatment, and a set of accounts your lender will actually accept. Whether you are an existing owner adding a second store or a first-time buyer, the NHS-contract layer is where most acquirers get caught out.
Selling a PharmacyA pharmacy sale is usually a one-time event and the largest financial transaction of an owner's career. The tax on the disposal is the whole game: Business Asset Disposal Relief charges CGT at 18% for 2026/27 on qualifying gains up to the £1 million lifetime limit per person, and standard CGT rates of 18% or 24% apply above it, with the annual exempt amount frozen at £3,000. The rate stepped up from 14% in 2025/26, so timing a sale around BADR rate steps is real money. We provide the exit-tax planning, valuation input, and deal-structuring advice that a pharmacy broker does not.
Pharmacy GroupsRunning two or more pharmacies through separate companies creates a corporation-tax exposure that does not exist at single-store level. The £50,000 small-profits rate threshold and the £250,000 main-rate threshold are divided by the number of associated companies, so a multi-store owner with separate entities loses lower-rate headroom and can push the whole group toward the 25% main rate without any increase in profit. Group structure, profit extraction, and multi-site VAT and payroll are the disciplines where a generalist accountant is genuinely outgunned by the combination of NHS-contract depth and group-tax mechanics.
Locum PharmacistsHMRC publishes a locum-pharmacist-specific page in its Employment Status Manual, reference ESM4270, and its position is more restrictive than many locum pharmacists realise. Employment status for a locum pharmacist is decided by the facts of each engagement, not by what the contract says or what everyone else in the sector does. This page covers the tax and status questions that are specific to pharmacist locums, deduplicated from the generic locum guidance on medical and contractor sites. The only conversion on this page is the take-home comparator tool and, for locums thinking about ownership, the route into our buying-a-pharmacy guidance.
Pharmacy revenue is reimbursement and remuneration under the Community Pharmacy Contractual Framework. Drug Tariff prices and service fees, not shop takings, determine what you are paid. No generalist accountant models this.
The FP34 submission cycle means cash arrives roughly two months after prescriptions are dispensed, with an advance on account. That lag is a structural working-capital requirement, not a one-off timing difference. At the same time, Drug Tariff and Category M clawbacks adjust gross margin retrospectively, which means margin variance analysis (not just bookkeeping) is the core monthly job.
We set up the accounting structure from scratch, separating reimbursement from remuneration and flagging the FP34 lag before it becomes a cash-flow problem.
Category M price changes and Drug Tariff clawbacks adjust gross margin retrospectively. We reconcile the NHSBSA payment schedule to your dispensing records and identify where margin has leaked.
NHS contract income is the primary driver of pharmacy valuation. We model reimbursement trends, FP34 history, and Category M exposure before you sign heads of terms.
Service income under Pharmacy First and similar schemes is a separately accounted revenue line with its own fee structure. We account for it correctly alongside core dispensing income.
NHS-dispensed prescription drugs are zero-rated for VAT. Most OTC retail sales are standard-rated. Private pharmacist services may be exempt or standard-rated depending on the service line. That mix means a pharmacy almost always reclaims more input VAT than a generalist expects.
Retail schemes split the takings where a pharmacy cannot itemise every sale. Choosing the wrong scheme systematically overpays VAT. We map your sales mix, select the correct scheme, and review whether the scheme in use has been right for your business.
| Supply type | VAT treatment |
|---|---|
| NHS-dispensed prescription drugs | Zero-rated (HP 1) |
| OTC retail medicines and health products | Standard-rated (HP 1) |
| Private pharmacist services | Exempt or standard-rated: map by service line (HP 2) |
| Input VAT on dispensing costs | Reclaimable against zero-rated outputs (HP 1) |
| Retail scheme apportionment | Splits zero-rated and standard-rated takings (HP 4) |
Market entry for community pharmacies in England is regulated under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013. The NHS contract, not the shop, is the asset. Share versus asset purchase structure, goodwill treatment, Business Asset Disposal Relief at 18% for 2026/27, and stamp duty versus SDLT: these are decisions that cannot be undone after contracts are signed.
Purchase price allocation, goodwill and NHS contract due diligence, share vs asset structure, SDLT, and post-acquisition accounting setup.
BADR eligibility review, CGT computation, asset vs share sale modelling, and pre-sale restructuring where the company structure needs work before exit.
Goodwill dominates pharmacy pricing. Corporation tax relief on goodwill is restricted on a company purchase. We advise on valuation methodology and purchase price allocation.
Retail schemes are the practical mechanic for splitting zero-rated and standard-rated takings in a pharmacy that cannot itemise every sale. The wrong scheme systematically overpays VAT, often for years before anyone notices. Because NHS-dispensed prescription drugs are zero-rated and most OTC retail is standard-rated, a pharmacy almost always reclaims more input VAT than a pure retailer expects. The scheme selection matters.
Pharmacy income is reimbursement and remuneration under the Community Pharmacy Contractual Framework, not shop takings. The FP34 submission cycle creates a roughly two-month lag between prescription dispensed and cash received. New owners and buyers frequently undermodel this working-capital requirement and arrive at completion underfunded.
Drug Tariff prices and Category M clawbacks set gross margin centrally and adjust it retrospectively. That makes margin variance analysis, not just bookkeeping, the core monthly job for a pharmacy. Most generalist accountants treat dispensing income as a single line; we reconcile reimbursement to the payment schedule and flag variance.
The corporation tax small profits rate (19%) threshold of £50,000 is divided by the number of associated companies. A four-pharmacy group with separate companies has a threshold of £12,500 per entity before the main 25% rate begins to phase in. Owners expanding without restructuring advice can pay materially more corporation tax than they need to.
All three calculators are scenario and estimate tools. They state their simplifications openly and end at “your situation has specific complexity, speak to us”. They never produce a filing-ready figure and never require sign-up or store data.
Model the purchase price you can service at different NHS contract income levels, deposit sizes and finance rates. A scenario tool that ends at 'speak to us before exchanging contracts'.
Estimate the working-capital requirement created by the FP34 submission-to-payment lag. Helps buyers and new owners model the cash cycle before it becomes a problem.
Compare estimated net income as a self-employed sole trader versus through a limited company for locum pharmacists. States its simplifications and routes complex IR35 situations to specialist advice.
A regularly updated index tracking community pharmacy openings and closures across England, drawing on NHS Business Services Authority openings and closures data and Companies House register records. The index carries its methodology and limitations prominently. It is a market-awareness resource for pharmacy buyers, sellers, and operators, not a regulatory filing or investment advice.
FP34 reconciliation, VAT retail scheme selection, Drug Tariff margin variance, share versus asset deal modelling, and the BADR eligibility check before exchange: a generalist encounters these infrequently. We work with them every week.
| Area | Our approach |
|---|---|
| NHS contract income and FP34 | We account for NHS reimbursement and remuneration as separate income streams, reconcile FP34 submissions to NHSBSA payments, and model the working-capital lag. A generalist treats dispensing income as a single bank receipt. |
| VAT retail scheme selection | NHS-dispensed prescription drugs are zero-rated; most OTC retail is standard-rated. We select and apply the correct retail scheme for your sales mix so you reclaim the input VAT you are entitled to, rather than the lower figure a wrong-scheme calculation produces. |
| Drug Tariff and Category M margin | Gross margin is set centrally by the Drug Tariff and adjusted retrospectively by Category M clawbacks. We run monthly margin variance analysis, not just end-of-year bookkeeping. |
| Buying and selling: share vs asset structure | An asset purchase attracts SDLT on property at non-residential rates (up to 5%); a share purchase attracts 0.5% stamp duty on shares but inherits the company's history. We model both structures before heads of terms are signed. |
| Business Asset Disposal Relief | BADR charges CGT at 18% for 2026/27 on qualifying disposals up to the £1m lifetime limit (per person). The qualifying conditions must be verified before exchange; timing a pharmacy sale around BADR rate changes is real money. |
| Multi-store group CT and VAT | The corporation tax small profits rate threshold (£50,000) is divided by associated companies. A pharmacy group without a reviewed structure pays more tax than it needs to and creates intercompany complexity that a generalist rarely untangles. |
Composite accounts based on patterns across our client base. Names, amounts and specific details anonymised. The situations described are real.
“Our previous accountant filed the VAT returns using the standard retail scheme. When the position was reviewed we discovered the wrong scheme had been applied for three years. The corrected position recovered a meaningful sum in input VAT we had overpaid. The scheme selection was the issue, not the bookkeeping.”
“I was buying my first pharmacy and underestimated how much working capital I needed to cover the period between dispensing and the NHSBSA paying the FP34. The cash-flow model built as part of the purchase review identified the gap before completion. I would have arrived at the till underfunded.”
“We had three pharmacies in separate companies and assumed we were getting the 19% small profits rate. The associated-company rules meant the threshold was divided three ways and we had been paying more corporation tax than we needed to. Restructuring the group sorted it.”
Tell us about your pharmacy, your buying or selling plans, or the question on your mind. We will explain what you need and what the position looks like, in plain English, with no obligation.
Guides on NHS contract income and FP34 cash flow, VAT on dispensing and OTC sales, buying and selling a pharmacy, goodwill and BADR, business structure, and locum pharmacist tax. Written for pharmacy owners and buyers, not for accountants.